Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WI › Mount Pleasant › NPI 1851044010
Lab

Covid Care Zone INC

Covid Care Zone INC was paid $3.61M by Medicaid between Feb 2022 and Apr 2023, across 5 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 46% of everything it billed.

33Billing provider infoCOVID CARE ZONE INC
MOUNT PLEASANT, WI 53406
33aNPI1851044010assigned 01/28/2022
28Total paid$3.61M
24GClaims93,584
24DCodes billed5
24AFirst – last monthFeb 2022 – Apr 2023
Compared with peers

Next to other Clinical Medical Laboratory providers in Wisconsin

Rank by total paid#17 of 75
Median peer was paid$106K
This provider vs. median34×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
202258,789$2.27M
202334,795$1.34M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 46% 22,480 10,250 $1.64M
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 25% 21,968 10,196 $887K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 15% 22,985 10,633 $525K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 14% 20,857 10,195 $508K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1.3% 5,294 1,904 $45K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialABDUL RAHMAN, MOHAMMED INFAS (PRESIDENT)